• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.65% Nasdaq Down1.89%

    BioCryst Pharmaceuticals, Inc. (BCRX)

    11.06 Down 0.27(2.38%) 4:00PM EST
    |After Hours : 11.06 Up 0.02 (0.14%) 4:00PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.2
    Mean Recommendation (last week):2.2

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:17.45
    Median Target:18.00
    High Target:24.00
    Low Target:8.00
    No. of Brokers:11

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Feb 28, 2014OppenheimerInitiated Perform
    Feb 20, 2014MizuhoInitiated Buy
    Feb 18, 2014NeedhamInitiated Buy
    Apr 9, 2013MLV & CoUpgradeHoldBuy
    Aug 14, 2012WBB SecuritiesDowngradeBuyHold
    Sep 29, 2010Rodman & RenshawUpgradeMkt PerformMkt Outperform
    Jan 29, 2010WBB SecuritiesInitiated Buy
    Oct 13, 2009JMP SecuritiesInitiated Mkt Outperform
    Sep 20, 2007Caris & CompanyDowngradeAbove AverageAverage
    Dec 11, 2006Caris & CompanyDowngradeAbove AverageAverage

    More Upgrades & Downgrades for BCRX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy1111

    Data provided by Thomson/First Call

    Currency in USD.